Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Yakugaku Zasshi ; 141(4): 599-610, 2021.
Artigo em Japonês | MEDLINE | ID: mdl-33790125

RESUMO

Elneopa NF No. 1 and No. 2 infusions are total parenteral nutrition solutions packaged in four-chambered infusion bags. They have been used as home parenteral nutrition, with various drugs injected into the infusion bags, for treating patient symptoms. In this study, we investigated the stability of six drugs, including famotidine, scopolamine butylbromide, furosemide, bromhexine hydrochloride, betamethasone sodium phosphate, and metoclopramide hydrochloride in the infusion bags under dark conditions at 4℃ for 7 days. Additionally, we developed a high-performance liquid chromatography method to determine drug concentrations in the infusions. The concentrations of injected famotidine, scopolamine butylbromide, and betamethasone sodium phosphate remained unchanged when the four chambers of Elneopa NF No. 1 and No. 2 were opened and the infusions were mixed. Their respective concentrations in the upper and lower chambers also remained unchanged. The concentration of furosemide in the upper chamber of the No. 1 infusion bag decreased after 5 days, although no change was observed in the other chambers and the mixed infusions with the four chambers opened. The concentration of bromhexine hydrochloride slightly decreased in the upper chambers (approximately 3%) after the co-infusion but decreased significantly in the other chambers and the mixed infusions with the four chambers opened. The concentration of metoclopramide hydrochloride significantly decreased in the upper chambers after the co-infusion; however, no change in concentration was observed in the other chambers and the mixed infusion with the four chambers opened. The results of this study provide useful information on home-based parenteral nutrition.


Assuntos
Betametasona/análogos & derivados , Bromoexina , Brometo de Butilescopolamônio , Embalagem de Medicamentos , Famotidina , Furosemida , Metoclopramida , Soluções de Nutrição Parenteral/análise , Nutrição Parenteral Total no Domicílio , Betametasona/análise , Bromoexina/análise , Brometo de Butilescopolamônio/análise , Estabilidade de Medicamentos , Famotidina/análise , Furosemida/análise , Metoclopramida/análise
2.
J Am Chem Soc ; 124(18): 4936-7, 2002 May 08.
Artigo em Inglês | MEDLINE | ID: mdl-11982339

RESUMO

A complexing reagent composed of two bipyridine moieties enabled the efficient separation of lithium chloride through liquid membrane from seawater, in which 0.005% lithium chloride is contained (more than 99% metal chlorides are NaCl, KCl, MgCl2, and CaCl2). That is, two separations by our liquid membrane changed the molar ratio of LiCl from 0.005% to 80%. The striking characteristic of this compound is that the lithium ion is separated efficiently from alkali and alkaline earth metal ions without the lipophilic anion. Thus this new membrane system contructed by us offers a low-energy, low-cost, and environmentally friendly method to enable the routine use of lithium chloride separation from seawater.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA